Literature DB >> 1375796

The distribution and possible function of gamma interferon-immunoreactive cells in normal endometrium and myometrium.

C J Stewart1, M A Farquharson, A K Foulis.   

Abstract

T-lymphocytes are present in normal endometrium, where they may have a role in the control of glandular maturation. T-cell activity could be related to the local secretion of cytokines such as gamma interferon, which has an anti-proliferative effect on endometrial epithelial cells in vitro. We have examined gamma interferon immunoreactivity and T-cell distribution in 24 normal pre-menopausal uteri. Endometrial appearances were representative of all stages of the menstrual cycle. Most cells in the lymphoid aggregates in the stratum basalis were stained by T-cell and gamma interferon antisera. T-lymphocytes were also scattered in glandular epithelium and throughout the stroma of basal and functional layers; immunoreactivity for gamma interferon was less consistent in these cells. There was no alteration in the intensity or distribution of gamma interferon staining in different phases of the menstrual cycle. Endometrial granulocytes (K-cells) present mainly in the late secretory endometria were not reactive with the gamma interferon antiserum. In addition to endometrial staining, T-cells were distributed in all areas of the myometrium in most uteri, and many myometrial lymphocytes were gamma interferon positive. These results support a role for gamma interferon in endometrial physiology, possibly as an inhibitor of epithelial proliferation.

Mesh:

Substances:

Year:  1992        PMID: 1375796     DOI: 10.1007/bf01600513

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  19 in total

1.  Evidence of T-cell activation and potential cytokine action in human endometrium.

Authors:  S Tabibzadeh
Journal:  J Clin Endocrinol Metab       Date:  1990-09       Impact factor: 5.958

2.  Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues.

Authors:  A J Norton; A D Ramsay; S H Smith; P C Beverley; P G Isaacson
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  An immunohistochemical study of lymphoid tissue in human endometrium.

Authors:  R J Marshall; D B Jones
Journal:  Int J Gynecol Pathol       Date:  1988       Impact factor: 2.762

4.  Endometrial lymphoid tissue: an immunohistological study.

Authors:  H Morris; J Edwards; A Tiltman; M Emms
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

5.  Immunocytochemical evidence that endometrial stromal granulocytes are granulated lymphocytes.

Authors:  J N Bulmer; D Hollings; A Ritson
Journal:  J Pathol       Date:  1987-11       Impact factor: 7.996

6.  The immunocytochemical distribution of leukocytic subpopulations in human endometrium.

Authors:  B R Kamat; P G Isaacson
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

7.  Variable expression of Ia antigens in human endometrium and in chronic endometritis.

Authors:  S S Tabibzadeh; A Bettica; M A Gerber
Journal:  Am J Clin Pathol       Date:  1986-08       Impact factor: 2.493

8.  Antiproliferative effect of interferon-gamma in human endometrial epithelial cells in vitro: potential local growth modulatory role in endometrium.

Authors:  S S Tabibzadeh; P G Satyaswaroop; P N Rao
Journal:  J Clin Endocrinol Metab       Date:  1988-07       Impact factor: 5.958

9.  Sex steroid receptors in lymphoid cells of human endometrium.

Authors:  S S Tabibzadeh; P G Satyaswaroop
Journal:  Am J Clin Pathol       Date:  1989-06       Impact factor: 2.493

10.  Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen.

Authors:  J R Klein; D H Raulet; M S Pasternack; M J Bevan
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  1 in total

1.  Thymidine phosphorylase expression in endometrial carcinomas.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis; R Bicknell; A L Harris; K C Gatter
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.